Percutaneous implantation of pulmonary valves for treatment of right ventricular outflow tract dysfunction

Cardiology in the Young

Volumn 18, Issue 3, 2008, Pages 260-267

  Lurz, Philipp ^a   Bonhoeffer, Philipp ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Conduit obstruction; Pulmonary regurgitation; Valved stent

Indexed keywords

ANTIBIOTIC AGENT;

ANATOMICAL VARIATION; CARDIOPULMONARY BYPASS; ENDOCARDITIS; FOLLOW UP; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HISTORY OF MEDICINE; HUMAN; OUTCOME ASSESSMENT; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVULOPLASTY; REVIEW; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; TRANSLUMINAL VALVULOPLASTY; TREATMENT INDICATION;

BALLOON DILATATION; HUMANS; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; PULMONARY VALVE; STENTS; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 44649166305     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951108002151     Document Type: Review

References (41)

1. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: A multicentre study. Lancet 2000; 356: 975-981.
2. Chan KC, Fyfe DA, McKay CA, Sade RM, Crawford FA. Right ventricular outflow reconstruction with cryopreserved homografts in pediatric patients: Intermediate-term follow-up with serial echocardiographic assessment. J Am Coll Cardiol 1994; 24: 483-489.
3. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: Changing prevalence and age distribution. Circulation 2007; 115: 163-172.
4. Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Turrentine MW. Right ventricular outflow tract reconstruction with an allograft conduit in non-Ross patients: Risk factors for allograft dysfunction and failure. Ann Thorac Surg 2005; 80: 655-663.
5. Powell AJ, Lock JE, Keane JF, Perry SB. Prolongation of RV-PA conduit life span by percutaneous stent implantation. Intermediate-term results. Circulation 1995; 92: 3282-3288.
6. Rastan AJ, Walther T, Daehnert I, et al. Bovine jugular vein conduit for right ventricular outflow tract reconstruction: Evaluation of risk factors for mid-term outcome. Ann Thorac Surg 2006; 82: 1308-1315.
7. Stark J, Bull C, Stajevic M, Jothi M, Elliott M, de Leval M. Fate of subpulmonary homograft conduits: Determinants of late homograft failure. J Thorac Cardiovasc Surg 1998; 115: 506-514.
8. Tweddell JS, Pelech AN, Frommelt PC, et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 2000; 102: III130-III135.
9. Fogelman R, Nykanen D, Smallhorn JF, McCrindle BW, Freedom RM, Benson LN. Endovascular stents in the pulmonary circulation. Clinical impact on management and medium-term follow-up. Circulation 1995; 92: 881-885.
10. Peng LF, McElhinney DB, Nugent AW, et al. Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: A 15-year experience. Circulation 2006; 113: 2598-2605.
11. Murphy JD, Freed MD, Keane JF, Norwood WI, Castaneda AR, Nadas AS. Hemodynamic results after intracardiac repair of tetralogy of Fallot by deep hypothermia and cardiopulmonary bypass. Circulation 1980; 62: I168.
12. Frigiola A, Redington AN, Cullen S, Vogel M. Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of Fallot. Circulation 2004; 110: II153-III157.
13. Carvalho JS, Shinebourne EA, Busst C, Rigby ML, Redington AN. Exercise capacity after complete repair of tetralogy of Fallot: Deleterious effects of residual pulmonary regurgitation. Br Heart J 1992; 67: 470-473.
14. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000; 356: 1403-1405.
15. Hufnagel CA, Harvey WP, Rabil PJ, McDermott TF. Surgical correction of aortic insufficiency. Surgery 1954; 35: 673-683.
16. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992; 13: 704-708.
17. Pavcnik D, Wright KC, Wallace S. Development and initial experimental evaluation of a prosthetic aortic valve for transcatheter placement. Work in progress. Radiology 1992; 183: 151-154.
18. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Transcatheter implantation of a bovine valve in pulmonary position: A lamb study. Circulation 2000; 102: 813-816.
19. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106: 3006-3008.
20. Boudjemline Y, Agnoletti G, Bonnet D, et al. Steps toward the percutaneous replacement of atrioventricular valves an experimental study. J Am Coll Cardiol 2005; 46: 360-365.
21. Boudjemline Y, Bonhoeffer P. Steps toward percutaneous aortic valve replacement. Circulation 2002; 105: 775-778.
22. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006; 113: 842-850.
23. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006; 114: 1616-1624.
24. Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: Results in 59 consecutive patients. Circulation 2005; 112: 1189-1197.
25. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-763.
26. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol 2007; 50: 69-76.
27. Mertens L. Deciphering the mystery of the leaky pulmonary valve in a new era of interventional cardiology. Eur Heart J 2007; 28: 1793-1794.
28. Costerhof T, van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007; 116: 545-551.
29. Buechel ER, Dave HH, Kellenberger CJ, et al. Remodelling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: Assessment by cardiovascular magnetic resonance. Eur Heart J 2005; 26: 2721-2727.
30. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005; 95: 779-782.
31. Therrien J, Sin SC, McLaughlin PR, Liu PP, Williams WG, Webb GD. Pulmonary valve replacement in adults late after repair of tetralogy of Fallot: Are we operating too late? J Am Coll Cardiol 2000; 36: 1670-1675.
32. Vliegen HW, van Straten A, de Roos A, et al. Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of fallot. Circulation 2002; 106: 1703-1707.
33. Therrien J, Warnes C, Daliento L, et al. Canadian Cardiovascular Society Consensus Conference 2001 update: Recommendations for the management of adults with congenital heart disease part III. Can J Cardiol 2001; 17: 1135-1158.
34. Sridharan S, Coats L, Khambadkone S, Taylor AM, Bonhoeffer P. Images in cardiovascular medicine. Transcatheter right ventricular outflow tract intervention: The risk to the coronary circulation. Circulation 2006; 113: E934-e935.
35. Coats L, Khambadkone S, Derrick G, et al. Physiological consequences of percutaneous pulmonary valve implantation: The different behaviour of volume- and pressure-overloaded ventricles. Eur Heart J 2007; 28: 1886-1893.
36. Coats L, Khambadkone S, Derrick G, et al. Physiological and clinical consequences of relief of right ventricular outflow tract obstruction late after repair of congenital heart defects. Circulation 2006; 113: 2037-2044.
37. Bonhoeffer P, Boudjemline Y, Qureshi SA, et al. Percutaneous insertion of the pulmonary valve. J Am Coll Cardiol 2002; 39: 1664-1669.
38. Nordmeyer J, Khambadkone S, Coats L, et al. Risk stratification, systematic classification and anticipatory strategies for stent fractures after percutaneous pulmonary valve implantation. Circulation 2007; 115: 1392-1397.
39. Boudjemline Y, Agnoletti G, Bonnet D, Sidi D, Bonhoeffer P. Percutaneous pulmonary valve replacement in a large right ventricular outflow tract: an experimental study. J Am Coll Cardiol 2004; 43: 1082-1087.
40. Boudjemline Y, Laborde F, Pineau E, et al. Expandable right ventricular-to-pulmonary artery conduit: An animal study. Pediatr Res 2006; 59: 773-777.
41. Boudjemline Y, Schievano, S, Bonnet C, et al. Off-pump replacement of the pulmonary valve in large right ventricular outflow tracts: A hybrid approach. J Thorac Cardiovasc Surg 2005; 129: 831-837.